Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. 8-K Event Acquisition or sale completed · Results of operations · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change · Regulation FD disclosure
  2. 8-K Event Executive or director change · Shareholder vote results · Other events
  3. S-4/A Deal Registration Statement - Business Combination
  4. S-4/A Deal Registration Statement - Business Combination
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 8-K Event Other events
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 8-K Event Shareholder vote results
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 8-K Event Executive or director change
  13. S-4 Deal Registration Statement - Business Combination
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 425 Deal Prospectus/Communication re Business Combination
  20. 425 Deal Prospectus/Communication re Business Combination

Page 2 of 5 · 86 filings